Streetbeat News

Revenues

OOMA

Ooma (NYSE:OOMA) reported Q1 2025 adjusted EPS of $0.14, beating the estimate of $0.11. Sales were $62.5M, surpassing the $61.844M estimate and showing a 9.93% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:16 pm

ICFI

The U.S. Environmental Protection Agency (EPA) has awarded a $75 million risk assessment contract to ICF International (ICFI). This contract is expected to enhance ICF's portfolio in environmental consulting and risk assessment services.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:15 pm

CAVA

CAVA has raised its FY24 same restaurant sales growth guidance from 3-5% to 4.5-6.5% and increased its adjusted EBITDA guidance from $86M-$92M to $100M-$105M.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:12 pm

APPS

Digital Turbine has provided its fiscal year 2025 revenue guidance, expecting between $540 million and $560 million, compared to the $553.18 million estimate. The company also projects non-GAAP adjusted EBITDA between $85 million and $95 million.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:11 pm

BMY

PRTA

Prothena will receive $80 million from Bristol Myers Squibb for an exclusive global license to PRX019. A Phase 1 clinical trial is set to begin in 2024.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:08 pm

BOX

Box (NYSE:BOX) reported Q1 2025 adjusted EPS of $0.39, beating the estimate of $0.36. Sales were $265 million, surpassing the $262.044 million estimate and showing a 5.20% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:05 pm

DRS

Leonardo DRS has been awarded a $26 million contract from NAVSEA for AN/SPQ-9B radar design agent and engineering services.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:03 pm

SXI

Six analysts have provided varied opinions on Standex International (NYSE:SXI) over the past quarter, with ratings ranging from bullish to somewhat bullish. The average 12-month price target has increased to $193.83, with a high estimate of $210.00 and a low estimate of $180.00. Recent analyst actions include maintaining and raising ratings, reflecting positive sentiment despite a recent revenue decline.

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 8:02 pm

CL

In the last three months, 12 analysts have provided ratings for Colgate-Palmolive (NYSE:CL), with a mix of bullish, somewhat bullish, and indifferent sentiments. The average 12-month price target has increased by 4.86% to $95.33. Analysts have raised their price targets, reflecting positive market sentiment and strong financial performance, including a 6.18% revenue growth rate and a net margin of 13.48%. However, the company faces challenges in debt management with a higher-than-average debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 8:01 pm

GDEV

GDEV (NASDAQ:GDEV) reported $107.00 million in sales for Q1, a 10.08% decrease from $119.00 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:01 pm